皮肤透过肝胆囊排水与皮肤透过肝胆道排水对于阻塞性黄的结果
Tetsushi Azami1, Yuichi Takano1, Naoki Tamai1
1Department of Medicine, Division of Gastroenterology, Showa University Fujigaoka Hospital, Yokohama, Japan.
PloS one
|February 24, 2025
概括
皮肤透过肝胆囊排水 (PTGBD) 在阻塞性黄中提供与皮肤透过肝胆道排水 (PTBD) 相似的结果. 当PTBD不可行时,PTGBD是一种可行的替代方案,表现出类似的成功率和并发症率.
科学领域:
- 干预性放射学 干预性放射学
- 肝胆道手术 肝胆道手术
- 胃肠病学 胃肠病学
背景情况:
- 阻塞性黄需要有效的胆道疏通程序.
- 皮肤透肝胆道排水 (PTBD) 是一种标准的治疗方法.
- 穿皮透肝胆囊排水 (PTGBD) 为特定的解剖学挑战提供了一个替代方案.
研究的目的:
- 追溯评估PTGBD与PTBD在治疗阻塞性黄方面的临床效用.
- 为了比较PTGBD和PTBD之间的技术成功,临床成功和并发症率.
- 为了确定PTGBD是否是一个合适的替代品,当PTBD不适合或不可行时.
主要方法:
- 追溯分析55名接受PTGBD或PTBD阻塞性黄和急性胆道炎的患者.
- 主要选择的是PTBD; PTGBD是根据特定的肝内胆道直径和可变性标准进行选择的.
- 排除标准包括胆道狭窄,后胆固醇胆,复杂胆囊炎,低胆红素和出血倾向.
主要成果:
- 技术成功率:PTGBD 96.3% (26/27) 与PTBD 82.1% (23/28) 相比.
- 临床成功率:PTGBD 85.2% (23/27) 和PTBD 67.9% (19/28). 临床成功率:PTGBD 85.2% (23/27) 和PTBD 67.9% (19/28). 临床成功率:PTGBD 85.2% (23/27) 和PTBD 67.9% (19/28). 临床成功率:PTGBD 85.2% (23/27) 和PTBD 67.9% (19/28).
- 并发症率:PTGBD 18.5% (5/27) 与PTBD 25.0% (7/28) 相比;在任何一组中都没有报告严重并发症.
结论:
- 在患有阻塞性黄的患者中,PTGBD的结果与PTBD相似.
- 在这个群体中,PTGBD的技术和临床成功率更高.
- 当PTBD不可行时,PTGBD是阻塞性黄的合理和有效的治疗选择.
相关概念视频
Diseases of the Liver and Gallbladder
411
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
411
Endoscopic Procedures V: ERCP
56
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
56
Acute Pancreatitis II: Clinical Manifestations and Management
80
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
80
Chronic Pancreatitis II: Collaborative Care
57
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
57


